Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 18 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 18, Issue 1 (March 2015) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Reach the widest possible audience in the shortest possible time Scientific Reports is the home for rapidly published, highly visible open access research. Multi-disciplinary in scope, we're open to all, publishing sound original research papers across the sciences without barriers to access.  What can we do for your research?    Reviews Top Global DNA hypomethylation in prostate cancer development and progression: a systematic review R Zelic, V Fiano, C Grasso, D Zugna, A Pettersson, A Gillio-Tos, F Merletti and L Richiardi Prostate Cancer Prostatic Dis 2015 18: 1-12; advance online publication, November 11, 2014; 10.1038/pcan.2014.45 Abstract | Full Text Original Articles Top Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population S P Kim, C P Gross, M C Smaldone, L C Han, H Van Houten, Y Lotan, R S Svatek, R H Thompson, R J Karnes, Q-D Trinh, A Kutikov and N D Shah Prostate Cancer Prostatic Dis 2015 18: 13-17; advance online publication, October 14, 2014; 10.1038/pcan.2014.38 Abstract | Full Text Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database R D Malik, C E Wang, B Lapin, G S Gerber and B T Helfand Prostate Cancer Prostatic Dis 2015 18: 18-24; advance online publication, October 14, 2014; 10.1038/pcan.2014.39 Abstract | Full Text Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin K Mitsuzuka, S Narita, T Koie, Y Kaiho, N Tsuchiya, T Yoneyama, N Kakoi, S Kawamura, T Tochigi, C Ohyama, T Habuchi and Y Arai Prostate Cancer Prostatic Dis 2015 18: 25-30; advance online publication, October 21, 2014; 10.1038/pcan.2014.40 Abstract | Full Text Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients F Moltzahn, J Karnes, P Gontero, B Kneitz, B Tombal, P Bader, A Briganti, F Montorsi, H Van Poppel, S Joniau and M Spahn Prostate Cancer Prostatic Dis 2015 18: 31-37; advance online publication, December 23, 2014; 10.1038/pcan.2014.41 Abstract | Full Text The association between race and treatment regret among men with recurrent prostate cancer B A Mahal, M-H Chen, C L Bennett, M W Kattan, O Sartor, K Stein, A V D'Amico and P L Nguyen Prostate Cancer Prostatic Dis 2015 18: 38-42; advance online publication, October 28, 2014; 10.1038/pcan.2014.42 Abstract | Full Text Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy C G Roehrborn, M E Spann, S L Myers, C R Serviss, L Hu and Y Jin Prostate Cancer Prostatic Dis 2015 18: 43-48; advance online publication, November 4, 2014; 10.1038/pcan.2014.43 Abstract | Full Text Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials D L Suzman, X C Zhou, M L Zahurak, J Lin and E S Antonarakis Prostate Cancer Prostatic Dis 2015 18: 49-55; advance online publication, November 11, 2014; 10.1038/pcan.2014.44 Abstract | Full Text Evaluation of PSF1 as a prognostic biomarker for prostate cancer H Tahara, H Naito, K Kise, T Wakabayashi, K Kamoi, K Okihara, A Yanagisawa, Y Nakai, N Nonomura, E Morii, T Miki and N Takakura Prostate Cancer Prostatic Dis 2015 18: 56-62; advance online publication, November 18, 2014; 10.1038/pcan.2014.46 Abstract | Full Text Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes M R Danzig, S Kotamarti, R A Ghandour, M B Rothberg, B P Dubow, M C Benson, K K Badani and J M McKiernan Prostate Cancer Prostatic Dis 2015 18: 63-68; advance online publication, November 18, 2014; 10.1038/pcan.2014.47 Abstract | Full Text Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer L-M Wong, S Ferrara, S M H Alibhai, A Evans, T Van der Kwast, G Trottier, N Timilshina, A Toi, G Kulkarni, R Hamilton, A Zlotta, N Fleshner and A Finelli Prostate Cancer Prostatic Dis 2015 18: 69-74; advance online publication, December 9, 2014; 10.1038/pcan.2014.48 Abstract | Full Text The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices C B Anderson, E B Elkin, C L Atoria, J A Eastham, P T Scardino and K Touijer Prostate Cancer Prostatic Dis 2015 18: 75-80; advance online publication, December 16, 2014; 10.1038/pcan.2014.49 Abstract | Full Text Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension R A Rakow-Penner, N S White, J K Parsons, H W Choi, M A Liss, J M Kuperman, N Schenker-Ahmed, H Bartsch, R F Mattrey, W G Bradley, A Shabaik, J Huang, D J A Margolis, S S Raman, L Marks, C J Kane, R E Reiter, D S Karow and A M Dale Prostate Cancer Prostatic Dis 2015 18: 81-85; advance online publication, January 6, 2015; 10.1038/pcan.2014.50 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.